The PEXIVAS study is funded by:
National Institutes of Health Research (UK): Number, HTA 08/56/04
National Institute for Health Research
Food and Drug Administration/National Institutes of Health (USA): FDA R01 FD003516
US Food and Drug Administration
National Institutes of Health (USA) - National Institute of Arthritis and Musculoskeletal and Skin Diseases: U54 AR0573319
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Health and Medical Research Council (Australia) 626939
Canadian Institutes of Health Research 211079